We are live on ! Find out more
JSAM

J. Safra Asset Management Portfolio holdings

AUM $2.17B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+84.26%
5 Year Est. Return
+107.54%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
+$177M
Cap. Flow
+$163M
Cap. Flow %
13.27%
Top 10 Hldgs %
70.93%
Holding
368
New
70
Increased
204
Reduced
21
Closed
27

Top Buys

Rank Stock Value
1
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$63.1M
2
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$41.9M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$40.6M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$39.9M
5
KIE icon
State Street SPDR S&P Insurance ETF
KIE
+$37.6M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$62.3M
2
XLU icon
State Street Utilities Select Sector SPDR ETF
XLU
+$39.1M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$37.7M
4
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$24.1M
5
XLI icon
State Street Industrial Select Sector SPDR ETF
XLI
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 1.72%
2 Consumer Discretionary 0.83%
3 Communication Services 0.66%
4 Financials 0.64%
5 Healthcare 0.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNWB icon
301
First Northwest Bancorp
FNWB
$108M
$6.36K ﹤0.01%
623
+272
+77% +$2.87K
PEN icon
302
Penumbra
PEN
$12.9B
$3.1K ﹤0.01%
13
– –
MASI
303
DELISTED
Masimo
MASI
$2.53K ﹤0.01%
15
+6
+67% +$947
PODD icon
304
Insulet
PODD
$10B
$2.37K ﹤0.01%
9
– –
ALNY icon
305
Alnylam Pharmaceuticals
ALNY
$29.4B
$1.65K ﹤0.01%
7
– –
SYK icon
306
Stryker
SYK
$134B
$1.45K ﹤0.01%
4
– –
REGN icon
307
Regeneron Pharmaceuticals
REGN
$83B
$1.41K ﹤0.01%
2
-1
-33% -$839
GKOS icon
308
Glaukos
GKOS
$10.7B
$1.2K ﹤0.01%
8
– –
EXAS
309
DELISTED
Exact Sciences
EXAS
$1.18K ﹤0.01%
21
+2
+11% +$124
PRVA icon
310
Privia Health
PRVA
$2.81B
$1.17K ﹤0.01%
60
+21
+54% +$416
VEEV icon
311
Veeva Systems
VEEV
$38.5B
$1.06K ﹤0.01%
5
+1
+25% +$220
INSP icon
312
Inspire Medical Systems
INSP
$1.75B
$923 ﹤0.01%
5
-1
-17% -$194
LEGN icon
313
Legend Biotech
LEGN
$4.22B
$918 ﹤0.01%
28
– –
MOH icon
314
Molina Healthcare
MOH
$10.3B
$868 ﹤0.01%
3
+1
+50% +$309
SGRY icon
315
Surgery Partners
SGRY
$1.99B
$741 ﹤0.01%
36
– –
PRCT icon
316
Procept Biorobotics
PRCT
$1.26B
$729 ﹤0.01%
9
– –
BTSG icon
317
BrightSpring Health Services
BTSG
$11.6B
$663 ﹤0.01%
+39
New +$674
RPRX icon
318
Royalty Pharma
RPRX
$26B
$658 ﹤0.01%
26
– –
BRKR icon
319
Bruker
BRKR
$8.61B
$644 ﹤0.01%
11
– –
LFST icon
320
Lifestance Health
LFST
$4.45B
$577 ﹤0.01%
78
– –
ALHC icon
321
Alignment Healthcare
ALHC
$2.8B
$569 ﹤0.01%
51
– –
TXG icon
322
10x Genomics
TXG
$7.73B
$560 ﹤0.01%
39
– –
NUVL
323
DELISTED
Nuvalent
NUVL
$545 ﹤0.01%
7
– –
JANX icon
324
Janux Therapeutics
JANX
$1.01B
$525 ﹤0.01%
10
+3
+43% +$159
BPMC
325
DELISTED
Blueprint Medicines
BPMC
$434 ﹤0.01%
5
-114
-96% -$10.4K
11 12
13
14 15

Similar funds

ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

J. Safra Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, J. Safra Asset Management held 368 positions worth $1.23B, up 17% from $1.05B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

J. Safra Asset Management deployed $163M of net new capital in Q4 2024, opening 70 new positions and adding to 204 existing holdings. Its largest new stake was State Street SPDR S&P Insurance ETF: 646,853 shares worth $36.5M.

By sector, the portfolio is most concentrated in Technology at 1.7% of assets, up from 1.2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $62.3M trimmed.

  • J. Safra Asset Management's largest Q4 2024 buy was State Street SPDR S&P Insurance ETF: 646,853 shares worth $36.5M.
  • J. Safra Asset Management added most to iShares Russell 1000 Growth ETF in Q4 2024, an estimated $63.1M increase.
  • J. Safra Asset Management's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $62.3M.
  • J. Safra Asset Management fully exited Carrier Global in Q4 2024, selling an estimated $196K.
  • J. Safra Asset Management's ten largest holdings make up 71% of its $1.23B portfolio in Q4 2024.
  • J. Safra Asset Management opened 70 new positions and closed 27 in Q4 2024.
  • J. Safra Asset Management's portfolio value rose 17% quarter-over-quarter to $1.23B.

Based on J. Safra Asset Management's 13F filing for Q4 2024, filed 6 Feb 2025.